Parallax Volatility Advisers, L.P. Viking Therapeutics, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 340,700 shares of VKTX stock, worth $8.74 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
340,700
Previous 114,600
197.29%
Holding current value
$8.74 Million
Previous $7.26 Million
88.96%
% of portfolio
0.03%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$261 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$126 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$66.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$55.3 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.97B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...